| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/25/2007 | US20070020231 Remedy for kidney diseases |
| 01/25/2007 | US20070017513 Method and apparatus for dispensing inhalator medicament |
| 01/25/2007 | US20070017508 Methods for treating jaw pain |
| 01/25/2007 | DE102005033630A1 Calcium-Peptid-Komponente Calcium peptide component |
| 01/25/2007 | DE102005033100B3 Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung New 1,4-benzothiazepine-1,1-Dioxidderivat with improved properties, these drug compound contained and processes for their preparation |
| 01/25/2007 | DE102005031576A1 Use of benzoic acid, pyrimidine and benzamide compounds, as activators of soluble guanylate cyclase for the treatment or prevention of reperfusion injury, |
| 01/25/2007 | CA2616156A1 Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system |
| 01/25/2007 | CA2615051A1 Use of soluble guanylate cyclase for the treatment of raynaud's phenomenon |
| 01/25/2007 | CA2614959A1 Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
| 01/24/2007 | EP1745779A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass |
| 01/24/2007 | EP1744782A1 Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof |
| 01/24/2007 | EP1744753A1 A method for the treatment or prevention of cardiac hypertrophy |
| 01/24/2007 | EP1744752A2 A method for the prevention of thromboembolic disorders |
| 01/24/2007 | EP1565485B1 Perindopril |
| 01/24/2007 | EP1461070B1 Combined use of a glp-1 compound and an aldose reductase inhibitor |
| 01/24/2007 | EP1363900B1 Isoindole-imide compounds, compositions and uses thereof |
| 01/24/2007 | EP1345594B1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1180028B1 Il-8 receptor antagonists |
| 01/24/2007 | EP1024812B1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
| 01/24/2007 | EP0970213B1 Death domain containing receptor 5 |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1901941A Conjugates of angiotensin ii and an imaging moiety |
| 01/24/2007 | CN1901938A Combination of a DPP-IV inhibitor and an anti-obesity or appetite regulating agent |
| 01/24/2007 | CN1901929A Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent |
| 01/24/2007 | CN1900100A Rehmannia root oligose and its extracting method |
| 01/24/2007 | CN1900082A Medicinal compound for resisting platelet activating factor |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1899615A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899614A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899606A Component for preventing and controlling heart diseases |
| 01/24/2007 | CN1899583A Blood vessel clearing capsule of pure Chinese medicine |
| 01/24/2007 | CN1899580A Anti-virus diluent |
| 01/24/2007 | CN1899544A Medicine for treating pile |
| 01/24/2007 | CN1899526A Chinese medicine for treating hypertension |
| 01/24/2007 | CN1899516A Medicine for treating coronary heart disease and arrhythmia caused cardio palmus and preparing method |
| 01/24/2007 | CN1899509A Chinese medicine injection for supplementing qi and recovering pulse and its preparing method |
| 01/24/2007 | CN1899507A Oral disintegration tablet for supplementing qi and recovering pulse and its preparing method |
| 01/24/2007 | CN1899506A Shenmai oral disintegration tablet and its preparing method |
| 01/24/2007 | CN1899502A Medicine for treating transient cerebral ischemia and its preparing method |
| 01/24/2007 | CN1899497A Chinese medicine preparation for treating coronary heart disease and cerebral arteriosclerosis and its preparing method |
| 01/24/2007 | CN1899460A Blood circulation promoting pill |
| 01/24/2007 | CN1899456A Qianjin pile pain ointment |
| 01/24/2007 | CN1899427A Chinese medicine composition with blood pressure reducing and tranquilizing function and its preparing method |
| 01/24/2007 | CN1899421A Chinese medicine composition for treating angiitis and phlebitis |
| 01/24/2007 | CN1899410A Medicine for treating cardiovascular disease and its preparing method and quality control method |
| 01/24/2007 | CN1899398A Medicine for treating cerebral thrombosis |
| 01/24/2007 | CN1899397A Heart activating oral disintergration tablet and its preparing method |
| 01/24/2007 | CN1899388A Shuangdan soft capsule and its preparing method |
| 01/24/2007 | CN1899373A Medicinal composition for treating coronary heart disease |
| 01/24/2007 | CN1899371A Use of white flower red sage root in medicine preparing field and method for prepaning white flower reasage root medicine |
| 01/24/2007 | CN1899369A Heart resurrecting injection preparation and its preparing method |
| 01/24/2007 | CN1899357A Method for producing persimmon frost medicine |
| 01/24/2007 | CN1899353A Compound Chinese medicine injection for supplementing qi and recovering pulse and its preparing method |
| 01/24/2007 | CN1899352A Chinese medicine effective part composition for supplementing qi and recovering pulse |
| 01/24/2007 | CN1899344A Process for preparing blumea balsamifera total flavone extract and blumea balsamifera flavone extract |
| 01/24/2007 | CN1899338A Chinese medicine composition for supplementing qi and promoting blood circulation |
| 01/24/2007 | CN1899328A Aescine oral disintegrant tablet and its preparing method |
| 01/24/2007 | CN1899324A Ginkgo Armillaria mellea oral preparation and its preparing method |
| 01/24/2007 | CN1899323A Ginkgo leaf extract, injection containing said extract and its preparing method |
| 01/24/2007 | CN1899319A Preparation of caterpillar fungus cephalosporin powder anti-arrhythmia effective part and its medicinal preparation |
| 01/24/2007 | CN1899297A Schefflera venulosa extract and use in producing medicine |
| 01/24/2007 | CN1899272A Stabilized compositions of aqueous reduced coenzyme q solution |
| 01/24/2007 | CN1899268A L-amlodipine besilate dripping pill and its preparing method |
| 01/24/2007 | CN1899267A Valsartan dripping pill and its preparing method |
| 01/24/2007 | CN1296386C Use of CD 25 binding molecules in steroid-resistant patients |
| 01/24/2007 | CN1296381C VEGF peptides and their use for inhibiting angiogenesis |
| 01/24/2007 | CN1296380C Pharmaceutical compound |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/24/2007 | CN1296075C Blood stasis-eliminating soft capsule and its preparation method |
| 01/24/2007 | CN1296074C Medicinal composition for treating coronary heart disease and preparation process thereof |
| 01/24/2007 | CN1296063C Compound red sage preparation for treating cardiac and cerebral vascular diseases and its preparation process |
| 01/24/2007 | CN1296061C Health care food for preventing and treating heart cerebrovascular and cardiovascular disease and its preparation method |
| 01/24/2007 | CN1296060C Compound ginkgo leaf preparation and its making method |
| 01/24/2007 | CN1296052C Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/24/2007 | CN1296049C Sustained release preparation for treating cardiovascular diseases, and preparation method, quality control method |
| 01/24/2007 | CN1296048C Ginseng and ophiopogon saponin drops pills and their preparing method |
| 01/24/2007 | CN1296046C Diltiazem hydrochloride control release capsule and its preparing method |
| 01/24/2007 | CN1296045C Dihydroergotoxine and its derivative oral disintegration tablet and its preparing process |
| 01/24/2007 | CN1296042C Acetyl salicyl sulfonone oral cavity disintegration tablet and its preparation method |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/24/2007 | CN1296037C Whole gastrodia tuber dripping pills and its preparing process |
| 01/23/2007 | US7166762 Method of constructing heart failure model animal |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166722 The monohydrochloric acid salt monohydrate, and its preparation by adding hydrochloric acid to a solution of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea in an N,N-dimethylformamide or N,N-dimethylacetamide aprotic solvent, adding ethanol and ethanol and water |
| 01/23/2007 | US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases |
| 01/23/2007 | US7166636 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166625 Method for treating fibrotic diseases and other indications |